Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,326 | 66,656 | 22,465 | 46,345 | 64,065 |
| Marketable Securities | 61,904 | 171,301 | 147,561 | 92,012 | 22,678 |
| Receivables | 2,384 | 3,473 | 1,010 | 28 | 14 |
| Inventories | 281 | 231 | 381 | N/A | N/A |
| TOTAL | $101,895 | $246,193 | $176,547 | $140,866 | $88,921 |
| Non-Current Assets | |||||
| PPE Net | 1,863 | 2,484 | 1,987 | 2,071 | 1,176 |
| Intangibles | 44,543 | 44,543 | 44,543 | 44,543 | 44,543 |
| Other Non-Current Assets | 36,686 | 5,200 | 6,352 | 6,819 | 2,269 |
| TOTAL | $83,092 | $52,227 | $52,882 | $53,433 | $47,988 |
| Total Assets | $184,987 | $298,420 | $229,429 | $194,299 | $136,909 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,595 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,083 | 14,801 | 14,389 | 10,395 | 9,152 |
| Accrued Expenses | 13,189 | 30,447 | 17,157 | 12,777 | 12,972 |
| TOTAL | $20,867 | $45,248 | $31,546 | $23,172 | $22,124 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,408 | 100,298 | 99,508 | 48,579 | N/A |
| Other Non-Current Liabilities | 7,174 | 6,924 | 5,265 | 5,424 | 1,190 |
| TOTAL | $56,582 | $107,222 | $104,773 | $54,003 | $1,190 |
| Total Liabilities | $77,449 | $152,470 | $136,319 | $77,175 | $23,314 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 423,681 | 361,492 | 246,237 | 188,726 | 149,594 |
| Common Shares | 366 | 363 | 245 | 189 | 150 |
| Retained earnings | -2,017,583 | -1,967,242 | -1,766,839 | -1,589,720 | -1,487,776 |
| Other shareholders' equity | -157 | 504 | 146 | -489 | 472 |
| TOTAL | $107,538 | $145,950 | $93,110 | $117,124 | $113,595 |
| Total Liabilities And Equity | $184,987 | $298,420 | $229,429 | $194,299 | $136,909 |